
    
      In this study the investigators evaluate the safety and efficacy of a probiotic formulation
      in the reduction of symptoms and use of topic and systemic corticosteroids and antihistamines
      in the treatment of mild atopic dermatitis according to Hanifin and Rajka diagnostic criteria
      for atopic dermatitis, with a SCORAD (Scoring Atopic Dermatitis) index of 20 to 40, in
      patients 4 to 18 years old, that require the use of said drugs due to disease flare-ups, and
      to whom the usage of topic corticoids to control said flare-ups is indicated.
    
  